載入...
Skin toxicity in a patient with ovarian cancer treated with pegylated liposomal doxorubicin: A case report and review of the literature
Pegylated liposomal doxorubicin (PLD) is a form of doxorubicin enclosed in pegylated liposomes. In contrast to conventional doxorubicin, PLD is characterized by a lower incidence of cardiotoxicity and myelosuppression. However, it induces specific mucocutaneous side effects, particularly palmar-plan...
Na minha lista:
| 發表在: | Oncol Lett |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
D.A. Spandidos
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228370/ https://ncbi.nlm.nih.gov/pubmed/28105242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.5309 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|